Literature DB >> 11518912

A study of human leukocyte antigen G expression in hydatidiform moles.

D Goldman-Wohl1, I Ariel, C Greenfield, D Hochner-Celnikier, Y Lavy, S Yagel.   

Abstract

OBJECTIVE: Human leukocyte antigen G (HLA-G) is a nonclassic major histocompatibility gene normally expressed only in extravillous trophoblasts throughout pregnancy. It may be responsible in part for the successful evasion of the hemiallogenic trophoblasts from maternal immune surveillance. We investigated whether HLA-G is expressed in molar pregnancies. STUDY
DESIGN: We examined 5 complete hydatidiform mole specimens and 5 partial hydatidiform mole specimens to determine whether HLA-G is expressed by immunohistochemistry and by RNA in situ hybridization analysis.
RESULTS: We found that both the protein and RNA of HLA-G is expressed in complete and partial hydatidiform moles.
CONCLUSION: HLA-G RNA and protein are expressed in molar pregnancies. HLA-G expression is independent of embryonic development and may therefore be an integral part of placental development. Furthermore, expression of HLA-G in the complete hydatidiform mole, a naturally occurring androgenote, confirms expression of the paternal allele of HLA-G. Imprinting of HLA-G is therefore unlikely to play a role in protecting fetal trophoblasts from maternal immune rejection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518912     DOI: 10.1067/mob.2001.115994

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  The relationship of 3'UTR HLA-G14-bp insertion/deletion and +3142 C/G polymorphisms and soluble HLA-G expression with gynecological cancers: An updated meta-analysis.

Authors:  Kalthoum Tizaoui; Maroua Jalouli; Nadia Boujelbene; Abdel Halim Harrath; Hadda-Imene Ouzari; Roberta Rizzo; Inès Zidi
Journal:  Immun Inflamm Dis       Date:  2022-07

2.  Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin.

Authors:  Robert J Oldt; Robert J Kurman; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

Review 3.  Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

4.  Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions.

Authors:  Xia Zhang; Aifen Lin; Qiu-Yue Han; Jian-Gang Zhang; Qiong-Yuan Chen; Yao-Han Ye; Wen-Jun Zhou; Hui-Hui Xu; Jun Gan; Wei-Hua Yan
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

Review 5.  HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers.

Authors:  Peilong Li; Nan Wang; Yi Zhang; Chuanxin Wang; Lutao Du
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.